CHEMICAL KINETICS AND STABILITY STUDIES OF AMLODIPINE BESYLATE

Authors

  • Vinesh Kumar L.B.S.College of Pharmacy, Jaipur, Rajasthan, India
  • Shiv Garg Maharishi Arvind College of Pharmacy, Ambabari, Jaipur- Rajasthan, India
  • Piush Sharma Maharishi Arvind College of Pharmacy, Ambabari, Jaipur- Rajasthan, India

DOI:

https://doi.org/10.22270/ajprd.v6i2.364

Keywords:

Amlodipine besylate, chemical kinetics, drug concentration, solubility

Abstract

The drug Amlodipine besylate was selected to study its chemical kinetics and degradation kinetics under variable conditions such as different temperatures, pH, light, buffers, solvent system and surfactants by applying the principles of chemical kinetics. The solubility of drug was checked in water and different solvents like Dimethyl formamide, methanol, ethanol, propylene glycol, PEG 400, PEG 600 and glycerol. The dug was found to be fully soluble in methanol, DMF, PEG 600, PEG 400, and Propylene glycol. The stock solution was then scanned between 200-400nm and the lmax was found to be 239 nm where the absorbance for 40 mg/ml was 1.1726 (Fig –1). The standard graph of the drug was plotted between concentration and absorbance whish gave a linear plot and the Lambert Beers law was obeyed in the concentration range of 0 to 30mg/ml.

Downloads

Download data is not yet available.

References

1. Rodney J. Wigent, In; Alfonso R Gennaro, Eds., Remington: The Science and Practice of Pharmacy, Vol. 1, 20th Edn., Lippincott Williams and Wilkins, Philadelphia, PA, 2000, 263-274.
2. Guillory J. Keith and Rolland I. Poust, In; Gilbert S. Banker and Christopher T. Rhodes, Eds., Modern Pharmaceutics, 3rd Edn., rev. and expanded, Marcel Dekker Inc., New York, 1996;179-210.
3. E.H. Dearborn, In; J.J. Windheuser and W.L. Blockstein, Eds., University Extension, University of Wisconsin, Medison, WI, 1970; 29.
4. K. Nord., J. Karlsen, and H.H. Tonnesen, Int. J. Pharm., 1991; 11, 72.
5. P.J.G. Carnelissen, G.M.J. Beijersbergen Van Henegouwen, and K.W. Gerritsma, Int. J. Pharm., 1978;1, 173.
6. K.A. Neftel, M. Walti, Spengler, and A.L. De Weck, Lancet, 1982;1, 986.
7. Kenneth A. Connors, Gordon L. Amidon, Valentino J. Stella, Eds., In; Chemical Stability of Pharmaceuticals, 2nd Edn., A Wiley-Interscience Publication, New York, 1986;32-154.
8. Leon Lachman, Patrick Deluca, and Michael J. Akers, In; Leon Lachman, Herbert A. Lieberman, and Joseph L. Kanig, Eds., The Theory and Practice of Industrial Pharmacy, 3rd Edn., Varghese Publishing House, Bombay, 1987; 760-803.
9. Alfred Martin, James Swarbrick, Arthur Cammarata, Eds., In; Physical Pharmacy, 3rd Edn., Varghese Publishing House, Bombay, 1991; 350-397.
10. Federal Register, 36: 601, January 15, 1971.
11. Enever R.E., In; E.A. Rawlins, Eds., Bentley`s textbook of Pharmaceutics, 8th Edn., ELBS/Bailliere Tindall, East Sussex, 1984; 140-172.
12. Subrahmanyam C. V. S., Eds., In; Textbook of Physical Pharmaceutics, 1st Edn., Vallabh Prakashan, Delhi, 1998; 1-53.
13. “Martindale” The extra pharmacopoeia, 1999; 32nd Edn., 822-3.
14. Shefter Eli, Ho-Leung Fung, and Oliva Mok, J. Pharm. Sci., 1973; May, 62(5), 791-4.
15. Mathews A. Nunes and Einar Brochmanm-Hanssew, J. Pharm. Sci., 1974; 63(5), 716-20.
16. Beatrice M.G., Stanaszek W.F., Allen L.V., Stanton G.K., Cevington T.R., Am. J. Hosp. Pharm., 1975;32, 1133-7.
17. Genton D. and U.W. Kesselving, J. Pharm, Sci., 1977;66(5), 676-680.
18. Pikal M. J., A.L.Lukes and J.E.Lang, J. Pharm. Sci., 1977;66(9), 1312-1316.
19. Barbara Lenard Mc Niff, Edward F. McNiff and Ho-Hung Fung, Am. J. Hosp. Pharm. Sci., 1979; 36, 173-177.
20. Newten D.W., Fung E.Y., Williams D.A., Am. J. Hosp. Pharm., 1981;38, 1314-9.
21. Pawelczyk, Ewaryst, Knitter, Barbara, Majewski, Wiktor, Acta Pol Pharm., 1986;43(3). 142-9.
22. Jain N.K., Patel V.V., Taneja L.N., Pharmazie, 1988; 43(4), 254-5.
23. Wood M.J., Irwin W.J., Scott D.K., J. Clin. Pharm., Ther, 1990; 15, 291-300.
24. Sanyude, Locock, Robert A., Pagliaro and LouisA., J. Pharm. Sci., 1991;80(7), 674-6.
25. Xu K., Zhang H., Wee L., Lu Y., Sun K., and Yao Z., Zhongguo Zhong Yao Za Zhi, 1992;157-9, 191-2.
26. Chiba, Kaoru, Takahashi, Masanao, Byokin Yakugaku, 18(1), 43-51.
27. Yoshioka S., Aso Y., Izntsu K., and Kojuna S., Pharm. Res., 1994;11, 1721-5.
28. Blondino., Frank E, Byron., and Peter R., Respir. Drug Delivery V, Program Proc., (Int. Symp.), 1996, 5th, 125-131.
29. Thoma K., Kubler N., and Reimann E., Pharmazie, 1997;52, 362-73.
30. Shahrekh Z., Lee E., Olivero A.G., Matameros R.A., Robarge K.D., Lee A., Weise K.J., Blackum B.K., and Powell M.F., Pharm. Res., 1998;15, 434-41.
31. Nahata M.C., Marosco R.S., and Hipple T.F., J. Am.Pharm Assoc. (Warh), 39, 375-7.
32. Ekpe, Anthony, Jacobsen, and Thomas, Drug Der. Ind. Pharm., 1999;1057-1065.
33. El-Khawas, Manal, Boraie, and Nabila A, Acta Pharmaceutical (Zagreh), 2000;50(3), 219-228.
34. Pagocki, Dariusz, Schaneich, Christian, J. Pharm. Sci., 89(4), 443-6.
35. Kotchecvar A.T., Perry D.A., Ucken F.M., Drug Dev Ind Pharm., 2002;28(2), 143-9

Published

2018-07-09

How to Cite

Kumar, V., Garg, S., & Sharma, P. (2018). CHEMICAL KINETICS AND STABILITY STUDIES OF AMLODIPINE BESYLATE. Asian Journal of Pharmaceutical Research and Development, 6(2), 87–92. https://doi.org/10.22270/ajprd.v6i2.364